---
layout: report
type: daily
topic_slug: chronic_migraine
topic_display: "Chronic Migraine"
date: 2025-11-08
run_id: chronic_migraine_20251108_060514
theme: "The Role of Neuromodulation Devices in Chronic Migraine Treatment"
persona: "Persona.PRIMARY_CARETAKER"
source_plan_path: "/home/runner/work/health_buddy_app/health_buddy_app/.results/chronic_migraine/weekly_plan/2025-11-03/plan.json"
permalink: /topics/chronic_migraine/daily/2025-11-08/chronic_migraine_20251108_060514/
title: "Chronic Migraine â€” 2025-11-08"
---

# Neuromodulation Devices for Chronic Migraine: A Caretaker's Actionable Guide

For those supporting loved ones with chronic migraine, understanding neuromodulation devices offers a vital path when traditional medications fall short. These innovative therapies directly alter nerve activity to disrupt pain signals, potentially reducing migraine frequency, intensity, and duration.

**Key Non-Invasive Devices:**

*   **Cefaly (tSNS - transcutaneous supraorbital neurostimulation):**
    *   **FDA Approval:** Acute treatment and prevention of episodic and chronic migraine (ages 18+).
    *   **Eligibility:** Generally for individuals experiencing frequent migraines.
    *   **Usage:** Preventive: 20 minutes daily. Acute: 60 minutes at migraine onset.
    *   **Side Effects:** Mild, temporary forehead paresthesia or skin irritation.
    *   **Contraindications:** Painful skin lesions on the forehead, implanted metallic or electronic devices in the head.
*   **eNeura sTMS (single-pulse transcranial magnetic stimulation):**
    *   **FDA Approval:** Acute treatment of migraine with aura and preventive treatment of migraine (ages 12+).
    *   **Eligibility:** Individuals with or without aura, for prevention or acute relief.
    *   **Usage:** Acute: 2 pulses at migraine onset, repeat up to 3 times/hour. Preventive: 4 pulses twice daily.
    *   **Side Effects:** Lightheadedness, tingling, tinnitus (rare).
    *   **Contraindications:** Implanted metallic devices in the head, cardiac pacemakers, epilepsy.
*   **gammaCore (nVNS - non-invasive vagus nerve stimulation):**
    *   **FDA Approval:** Acute treatment of pain associated with episodic and chronic cluster headache, and episodic and chronic migraine (ages 12+).
    *   **Eligibility:** Broad, for both acute and preventive use.
    *   **Usage:** Acute: 2-minute treatment, repeat as needed (up to 24 minutes/day). Preventive: 2-minute treatment, 2-4 times daily.
    *   **Side Effects:** Mild skin irritation, neck/jaw discomfort.
    *   **Contraindications:** Implanted medical devices (e.g., pacemakers, hearing aids), carotid atherosclerosis.

**Practical Considerations for Caretakers:**

*   **Monitoring & Tracking:** Consistent tracking is crucial. Use a migraine diary or app to log:
    1.  Number of migraine days/month
    2.  Migraine intensity (0-10 scale)
    3.  Duration of attacks
    4.  Associated symptoms (nausea, light sensitivity)
    5.  Usage of rescue medications
    6.  Device usage frequency and duration
*   **Cost & Insurance:** Devices typically range from $300-$600 for initial purchase, with ongoing costs for electrodes/gel. Insurance coverage varies widely; some plans cover specific devices or require prior authorization. Always check with the insurer.
*   **Key Questions for the Neurologist:**
    *   Which device is most appropriate for their specific migraine pattern?
    *   What are the expected timelines for seeing results?
    *   How will we measure success?
    *   What are the financial implications and insurance coverage?
    *   How often will follow-up appointments be needed?

Empowering yourself with this knowledge allows you to advocate effectively for the best possible care, integrating these devices into a comprehensive migraine management plan.
